Psma inhibitor, compound and application
AssigneePeking University First Hospital
InventorsXing YANG, Zhi YANG, Zhen XI, Futao LIU, Xiaojiang DUAN
Life of this patent
Estimating the term…
Abstract
The present disclosure belongs to the technical field of biomedicine, and specifically relates to a PSMA inhibitor, compound and use thereof. The PSMA inhibitors having a novel core structure provided in the present disclosure has a wide range of potential applications.
Claims16
A compound, which a compound having the structure of Formula I or a pharmaceutically acceptable salt thereof,
- wherein Q1, Q2 and Q3 are each independently H, a negative charge, a metal ion, or a protecting group.
2-3. (canceled).
A compound, which is at least one of a compound having the structure of Formula II or a pharmaceutically acceptable salt thereof,
- wherein Q1, Q2 and Q3 are each independently H, a negative charge, a metal ion, or a protecting group, and R is a functional group.
9-11. (canceled).
The compound according to claim 7, wherein Z is selected from the group consisting of a substituted or unsubstituted C6-C16 aryl and a substituted or unsubstituted C3-C16 heteroaryl. cm 20. The compound according to claim 19, wherein the substitution is at least one of a halogen substitution, a linear or branched C1-C4 alkyl substitution, an amino substitution, or a carbonyl substitution.
Dependencies are inferred from the claim text.